These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9888469)

  • 1. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
    Kristensen CA; Askenasy N; Jain RK; Koretsky AP
    Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of creatine kinase isoenzymes and substrates on regeneration in livers of transgenic mice.
    Askenasy N; Koretsky AP
    Am J Physiol; 1997 Aug; 273(2 Pt 1):C741-6. PubMed ID: 9277372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
    Lillie JW; O'Keefe M; Valinski H; Hamlin HA; Varban ML; Kaddurah-Daouk R
    Cancer Res; 1993 Jul; 53(13):3172-8. PubMed ID: 8319226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo (1)H MRS and (31)P MRSI of the response to cyclocreatine in transgenic mouse liver expressing creatine kinase.
    Cui MH; Jayalakshmi K; Liu L; Guha C; Branch CA
    NMR Biomed; 2015 Dec; 28(12):1634-44. PubMed ID: 26451872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
    Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
    Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
    Hoosein NM; Martin KJ; Abdul M; Logothetis CJ; Kaddurah-Daouk R
    Anticancer Res; 1995; 15(4):1339-42. PubMed ID: 7654018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.
    Schiffenbauer YS; Meir G; Cohn M; Neeman M
    Am J Physiol; 1996 Jan; 270(1 Pt 1):C160-9. PubMed ID: 8772441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
    Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R
    Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumors.
    Schimmel L; Khandekar VS; Martin KJ; Riera T; Honan C; Shaw DG; Kaddurah-Daouk R
    Anticancer Res; 1996; 16(1):375-80. PubMed ID: 8615639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
    Matthews RT; Yang L; Jenkins BG; Ferrante RJ; Rosen BR; Kaddurah-Daouk R; Beal MF
    J Neurosci; 1998 Jan; 18(1):156-63. PubMed ID: 9412496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rate of tumor growth by creatine and cyclocreatine.
    Miller EE; Evans AE; Cohn M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3304-8. PubMed ID: 8475072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog.
    Holtzman D; Meyers R; O'Gorman E; Khait I; Wallimann T; Allred E; Jensen F
    Am J Physiol; 1997 May; 272(5 Pt 1):C1567-77. PubMed ID: 9176148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index.
    Kristensen CA; Kristjansen PE; Brünner N; Quistorff B; Spang-Thomsen M
    Cancer Res; 1995 Sep; 55(18):4146-50. PubMed ID: 7664292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
    Kornacker M; Schlattner U; Wallimann T; Verneris MR; Negrin RS; Kornacker B; Staratschek-Jox A; Diehl V; Wolf J
    Int J Cancer; 2001 Nov; 94(4):513-9. PubMed ID: 11745437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate.
    LoPresti P; Cohn M
    Biochim Biophys Acta; 1989 Oct; 998(3):317-20. PubMed ID: 2804134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
    Mulvaney PT; Stracke ML; Nam SW; Woodhouse E; O'Keefe M; Clair T; Liotta LA; Khaddurah-Daouk R; Schiffmann E
    Int J Cancer; 1998 Sep; 78(1):46-52. PubMed ID: 9724093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.
    Bottomley PA; Weiss RG
    Radiology; 2001 May; 219(2):411-8. PubMed ID: 11323465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs.
    Wiseman RW; Kushmerick MJ
    J Biol Chem; 1995 May; 270(21):12428-38. PubMed ID: 7759484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.
    Maril N; Degani H; Rushkin E; Sherry AD; Cohn M
    Am J Physiol; 1999 Oct; 277(4):C708-16. PubMed ID: 10516101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms.
    in 't Zandt HJ; de Groof AJ; Renema WK; Oerlemans FT; Klomp DW; Wieringa B; Heerschap A
    J Physiol; 2003 May; 548(Pt 3):847-58. PubMed ID: 12640020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.